The Attorney General's office says that non-alcoholic beverages with hemp-derived tetrahydrocannabinol (THC) with concentrations of delta-9 THC of no more than 0.3% are legal in South Carolina, assuming you can verify they meet this threshold.
A recent opinion published by South Carolina’s Office of the Attorney General states that non-alcoholic beverages that contain hemp-derived tetrahydrocannabinol (THC) with concentrations of delta-9 THC of no more than 0.3% are legal in South Carolina. The opinion was in response to an inquiry from Representative G. Murrell Smith Jr., the state’s Speaker of the House.
Smith wrote in a letter to the Attorney General’s (AG) office that “Recently, South Carolina distributors have been requested to provide hemp-infused beverages to various retailers in South Carolina…No statute, regulation, agency guidance or prior Attorney General Opinion I [sic] provides a clear answer as to whether these hemp-infused beverages that are manufactured, distributed, or sold in South Carolina are legal…Manufacturers and distributors in South Carolina need clear guidance.”
The opinion from the AG’s office explains that the passage of the 2018 Farm Bill removed hemp from the classification of a controlled substance and was therefore made legal, so long as the concentration of THC remained at or below 0.3%. It does, however, state that the AG’s office cannot make a “blanket” determination on the legality of this category of products without knowing whether each product meets this threshold of THC. This must be made on a case-by-case basis, says the opinion. Essentially, without a regulatory framework that ensures consistency across products, the AG cannot for sure know if every product marketed this way is legal.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.